Evidence map›Paper›PMID 23525012›Full record

ArticleJournal of cell science2013

Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro.

Sonali Sonnylal, Shiwen Xu, Helen Jones, Angela Tam, Vivek R Sreeram, Markella Ponticos, Jill Norman, Pankaj Agrawal, David Abraham, Benoit de Crombrugghe

Abstract read
In one paragraph

Article in Journal of cell science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Drugs targeting CTGF in the treatment of pulmonary fibrosis.Journal of cellular and molecular medicine · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of infected epithelial cells inFrontiers in cellular and infection microbiology · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Involvement of caveolin-1 in skin diseases.Frontiers in immunology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. PDGF Promotes Dermal Fibroblast ActivationFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sonali SonnylalUniversity of Texas M. D. Anderson Cancer Center, Department of Genetics, Houston, TX, USA. bloom.sonal@gmail.com
Shiwen Xu
Helen Jones
Angela Tam
Vivek R Sreeram
Markella Ponticos
Jill Norman
Pankaj Agrawal
David Abraham
Benoit de Crombrugghe
The Royal Free Hospital · GBThe University of Texas MD Anderson Cancer Center · USUniversity College London · GB

Funding

Role of TGF-beta and CTGF Signaling Transgenic Mouse Models of SclerodermaP50AR054144 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CROMBRUGGHE, BENOIT DE · 2006 to 2010
$7.7M
Arthritis Research UK 18627Arthritis Research UK 19427British Heart Foundation PG/11/92/29126Medical Research Council G0801052NIAMS NIH HHS P50 AR054144NIAMS NIH HHS P50AR054144Versus Arthritis 18627Versus Arthritis 19427
6 · The paper itself

Abstract

Connective tissue growth factor (CTGF) plays an important role in the pathogenesis of chronic fibrotic diseases. However, the mechanism by which paracrine effects of CTGF control the cell fate of neighboring epithelial cells is not known. In this study, we investigated the paracrine effects of CTGF overexpressed in fibroblasts of Col1a2-CTGF transgenic mice on epithelial cells of skin and lung. The skin and lungs of Col1a2-CTGF transgenic mice were examined for phenotypic markers of epithelial activation and differentiation and stimulation of signal transduction pathways. In addition to an expansion of the dermal compartment in Col1a2-CTGF transgenic mice, the epidermis was characterized by focal hyperplasia, and basal cells stained positive for αSMA, Snail, S100A4 and Sox9, indicating that these cells had undergone a change in their genetic program. Activation of phosphorylated p38 and phosphorylated Erk1/2 was observed in the granular and cornified layers of the skin. Lung fibrosis was associated with a marked increase in cells co-expressing epithelial and mesenchymal markers in the lesional and unaffected lung tissue of Col1a2-CTGF mice. In epithelial cells treated with TGFβ, CTGF-specific siRNA-mediated knockdown suppressed Snail, Sox9, S100A4 protein levels and restored E-cadherin levels. Both adenoviral expression of CTGF in epithelial cells and treatment with recombinant CTGF induced EMT-like morphological changes and expression of α-SMA. Our in vivo and in vitro data supports the notion that CTGF expression in mesenchymal cells in the skin and lungs can cause changes in the differentiation program of adjacent epithelial cells. We speculate that these changes might contribute to fibrogenesis.

Indexed as

Epithelial-Mesenchymal TransitionAnimalsBiomarkersCell DifferentiationCells, CulturedCollagen Type IConnective Tissue Growth FactorFibroblastsFocal Epithelial HyperplasiaLungMAP Kinase Signaling SystemMiceMice, TransgenicParacrine CommunicationPulmonary FibrosisRNA, Small InterferingBiomarkersCollagen Type IConnective Tissue Growth FactorRNA, Small InterferingTransforming Growth Factor betaCTGFDermal fibrosisEpithelial–mesenchymal transitionPulmonary fibrosis

Identifiers

PMID23525012
PMCPMC3672936
OpenAlexW2050423426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.